What new treatments are there for relapsed acute myeloid leukemia?

During the ESH 3rd How to Diagnose and Treat Acute Leukaemias, Know AML was pleased to speak with Jorge Sierra, Hospital de la Santa Creu i Sant Pau, Barcelona, ES. We asked, What new treatments are there for relapsed acute myeloid leukemia?

Sierra begins by outlining new chemotherapy combinations, including recently approved agents like venetoclax and CPX-351. He highlights the importance of venetoclax, and immunotherapies and combinations with molecular agents. He goes on to discuss the role of CAR T-cells and allogeneic transplants in acute myeloid leukemia treatment.

All content on Know AML is primarily intended for patients and caregivers. If you are a healthcare professional, please visit the AML Hub.

Please get in touch if you have any questions about Know AML or if you would like to discuss a potential collaboration.

Brought to you by

Scientific Education Support

In collaboration with

Thank you to the funders of Know AML. All content is developed independently by SES in collaboration with an expert ambassador group; funders are allowed no influence on the content of Know AML.

v2.29.00